Workflow
荣昌生物:2025一季报净利润-2.54亿 同比增长27.22%
Tong Hua Shun Cai Bao·2025-04-28 09:26

Financial Performance - The company reported a basic earnings per share of -0.4600 yuan for Q1 2025, an improvement of 29.23% compared to -0.6500 yuan in Q1 2024 [1] - The total revenue for Q1 2025 was 5.26 billion yuan, representing a significant increase of 59.39% from 3.3 billion yuan in Q1 2024 [1] - The net profit for Q1 2025 was -2.54 billion yuan, which is a 27.22% improvement from -3.49 billion yuan in Q1 2024 [1] - The company's net asset return rate was -13.61% in Q1 2025, a decline from -10.72% in Q1 2024 [1] Shareholder Information - The top ten unrestricted shareholders collectively hold 23,806.06 million shares, accounting for 67.72% of the circulating shares, with a decrease of 2.28 million shares compared to the previous period [2] - HKSCC NOMINEES LIMITED remains the largest shareholder with 18,956.67 million shares, representing 53.93% of the total share capital, unchanged from the previous period [3] - The company has seen a new entry in the top ten shareholders with Shanghai Liyi Investment Management Partnership holding 3,062.2 thousand shares [3] Dividend Policy - The company has announced that it will not distribute dividends or transfer shares this time [4]